Commerzbank Aktiengesellschaft’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,390	Closed	-$288K	–	1104
2016 Q1	$288K	Buy	+5,390	New	+$398K	﹤0.01%	881

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Commerzbank Aktiengesellschaft's ANAC Position: Q2 2016 in Review

Commerzbank Aktiengesellschaft sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 5,390 shares — an estimated $288K sold.

Commerzbank Aktiengesellschaft first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $288K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Commerzbank Aktiengesellschaft reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 5,390 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $288K.
Commerzbank Aktiengesellschaft first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
Commerzbank Aktiengesellschaft's ANACOR PHARMACEUTICALS INC COM position peaked at $288K in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2016, filed 1 Aug 2016.